Bioactive Compounds
-
A3613 MK-2894Summary: EP4 receptor inhibitor -
A3618 MK-51722 CitationSummary: Selective inhibitor of hepatitis C virus (HCV) NS3/4A protease -
A3623 MK-6892Summary: Highly potential GPR109A agonist -
A3629 MLN4924 HCl saltTarget: NAESummary: NAE inhibitor -
A3645 NB-598Summary: SE inhibitor -
A3658 NG25Summary: TAK1 inhibitor -
A3670 NucleozinSummary: Targets influenza A nucleoprotein (NP),cell-permeable isoxazolylpiperazine compound -
A3681 OlmesartanSummary: Angiotensin II receptor antagonist -
A3686 OrteronelSummary: For castration-resistant prostate cancer, clinical candidate -
A3699 PAP-1Summary: Kv1.3 inhibitor

